Opus Genetics, Inc.
IRD· Nasdaq
IRDOpus Genetics, Inc.
Filed Mar 16, 2012 · 10-K · 76 days after period end · 0001140361-12-016054
derived · Computed from the longer spans the company filed.
| Metric | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures |
|---|---|---|
| Revenue | $0.00 | — |
| Net Income | $389.28K | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Opus Genetics, Inc. · CIK 1228627 · Engraved from SEC EDGAR
ended Dec 31, 2011 · filed Mar 16, 2012 · 76 d after period end
